Our portfolio

Evolis is specialized in the design, manufacture and marketing of printers for graphic personalization and data encoding plastic cards (access control badges, credit cards, student cards, loyalty to subscription, transport, driving license, etc..).

Founded in 2007, Guo Cui is one of the largest potted plant (foliage plants and fresh flowers) production, sales and trading companies in China. Guo Cui has 3 main business streams: B2B wholesale, B2C retail and trading center which provides both logistics and warehousing services to clients.

ADA Cosmetics manufactures and sells high-quality personal care products such as shampoo, body lotion and soap for the hotel industry. The products are sold under ADA Cosmetics’, which owns Naturals, Pure Herbs and Hydro Basics brands. The product range also includes hotel cosmetics products from leading international brands including Chopard, Bulgari and Trussardi. Ardian will help ADA strengthen its position in the wider European and Asian markets.

EFS is one of the major US fleet card provider to Over-The-Road (“OTR”) trucking companies which operates heavy trucks fleets with focus on the long-haul and inter-state US routes). EFS equips drivers with payment cards to purchase in its network of 11,000 fuel stations and giving them rebates. EFS customizes cards to clients’ fuel cost control needs and provides intelligence reporting on fleet activity. EFS has replicated its expertise to penetrate employees’ corporate payment cards wide market with value-added data processing services and spending control functionalities.

Spie batignolles is one of the leading unlisted players in the French construction market. The Group has five divisions: construction, civil engineering, energy, public works, property development and concessions. Operating from 160 locations across France with 7,000 employees, the Group achieved a turnover of more than €2.1 billion in 2013.

The Bio 7 group is the leading operator of routine clinical pathology laboratories in Essonne, Seine et Marne and Yvelines, which are departments located in the French Île-de-France region. The Group operates 56 point-of-care laboratories and three high-performance technical platforms. In 2014, the Bio 7 group expects net revenues in excess of €55 million, a sharp increase on 2013. More than 95% of the Group’s revenues are derived from routine clinical pathology.